Intra-Cellular Therapies
ITCI
#1824
Rank
โ‚น763.49 B
Marketcap
โ‚น7,202
Share price
-0.39%
Change (1 day)
47.59%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -โ‚น132.73

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -โ‚น135.91. In 2022 the company made an earnings per share (EPS) of -โ‚น229.61 an increase over its 2021 EPS that were of -โ‚น295.46.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น132.73-42.19%
2022-โ‚น229.61-22.29%
2021-โ‚น295.468.02%
2020-โ‚น273.5120.9%
2019-โ‚น226.24-5.63%
2018-โ‚น239.7433.96%
2017-โ‚น178.96-21.19%
2016-โ‚น227.08-7.56%
2015-โ‚น245.65174.53%
2014-โ‚น89.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น21.10-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น844.17 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น180.65 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA